The EurOPDX Consortium is a scientific network of non-for-profit research institutions organised by a Consortium Agreement, and currently funded by Membership Fees contributed by each member institution according to its level of membership. One of our activities is to leverage funding for the Consortium infrastructure, as well as for specific collaborative research projects.
The main governing body of the Consortium is the Board of Coordinators, composed of one representative of each Full Member (see below). The Steering Committee is voting whenever all EurOPDX members need to be consulted. The Scientific Steering Committee, composed of one representative from all different research teams, is consulted for all scientific aspects.
(BC, Full members) = strategic decisions & management of the initiative
Frederic Amant (KUL), Alejandra Bruna (CRUK Cambridge Institute), Annette Byrne (RCSI),
Manuel Hidalgo (CNIO),Giorgio Inghirami (WCM), Steven de Jong (UMCG), Jos Jonkers (NKI),
Pier Giuseppe Pelicci (IEO),Alejandro Piris (VHIO), Sergio Roman-Roman (IC), Livio Trusolino (UNITO),
Alberto Villanueva (ICO/IDIBELL)
(SC, all centres represented) = consulted by the BC and voting for specific topics
(SSC, all individual res. teams represented) = discussions for the perfomance or not of a particular study by the Consortium
Logistics, Ethics, Bio-info-statistics,..., as well as pathology-specific WGs
Ad Hoc, for each research program of multicentre trial
The activities of the Consortium are organised in different working groups, including the following:
- Ethics (Leader Dr. Laura Soucek, VHIO, Spain): ensure that the network is in absolute compliance with national and European ethical rules;
- Logistics (Leader Dr. Andrea Bertotti, IRCC, University of Torino, Italy) : lead the establishment of the shared data management system and implement the logistics for the performance and quality of multicentre trials;
- Bio-info-statistics (Leader Dr. Eva Budinska, Masaryk University, Czech Republic): centralise discussions on common standards for molecular characterisation of PDX models, and drive data analyses and biostatistics for multicentre research programs;
- 2D/3D models (Leader Dr. Alejandra Bruna, Cambridge, UK): gathers EurOPDX scientists interested in developing 2D/3D models from the PDX models, as an alternative to in vivo work and in line with the 3R.
- Breast / colorectal ... cancer : centralise discussions related to a particular pathology, with regards to standards, protocols, collaborative multicentre studies...Would you like to join the Consortium and participate in these activities, or contact us with any question? Please email us here.